Suchergebnisse - "Igarashi, Ataru"

PubPharm (226)

1

The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan

enthalten in: Vaccines | 2024

von Fust, K. | Joshi, K. | Beck, E. | +6

2

Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine

enthalten in: Vaccine | 2024

von Kohli, M. | Maschio, M. | Lee, A. | +1

3

A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan

enthalten in: Epilepsy & behavior : E&B | 2024

von LoPresti, M. | Igarashi, A. | Sonohara, Y. | +1

4

Reduction in all-cause medical and caregiving costs through innovative health awareness projects in a rural area in Japan : a retrospective cohort study

enthalten in: BMC health services research | 2024

von Shoji, A. | Kudo, K. | Murashita, K. | +2

5

Reduction in all-cause medical and caregiving costs through innovative health awareness projects in a rural area in Japan: a retrospective cohort study

enthalten in: BMC health services research | 2024

von Shoji, A. | Kudo, K. | Murashita, K. | +2

6

Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs : Evaluation of data from a Japanese claims database

enthalten in: Modern rheumatology | 2024

von Harigai, M. | Fujii, T. | Sakai, R. | +9

ErratumIn: Mod Rheumatol. 2023 May 24;:. - PMID 37225887

7

Cost-effectiveness of surveillance intervals after curative resection of colorectal cancer

enthalten in: Japanese journal of clinical oncology | 2024

von Takayama, Y. | Tsukamoto, S. | Kudose, Y. | +5

8

Optimal age to discontinue long-term surveillance of intraductal papillary mucinous neoplasms : comparative cost-effectiveness of surveillance by age

enthalten in: Gut | 2024

von Hamada, T. | Oyama, H. | Igarashi, A. | +8

9

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan : vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)

enthalten in: Expert review of vaccines | 2024

von Maeda, H. | Saito, N. | Igarashi, A. | +29

10

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan : results of a Markov model analysis

enthalten in: Expert review of vaccines | 2024

von Kurai, D. | Mizukami, A. | Preckler, V. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]